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The purpose of this study was to develop a sensitive, rapid, and inexpensive immunofluorescence assay (IFA)
using a recombinant porcine circovirus type 2 (PCV2) nucleocapsid protein for the serological detection of
PCV2-specific antibodies in pig sera. The viral nucleocapsid protein encoded by the PCV2 ORF2 gene has
recently been identified as the most immunoreactive viral protein that carries type-specific antigenic deter-
minants. The ORF2 sequence of the IAF-2897 strain of PCV2 has been cloned into a pCEP5 eucaryotic
expression vector under the control of the cytomegalovirus promoter, downstream of a polyhistidine sequence
tag. The recombinant plasmid was used in transfection experiments with human epithelial kidney 293 cells that
were further tested, and positive expression of the viral nucleocapsid protein was confirmed by IFA and
Western blotting. Strong, specific fluorescence was observed in the nuclei of transfected cells. Test specificity
to PCV2 was verified with several related infectious agents. Sensitivity was compared to that of standard IFA
using PCV2-infected cells by evaluating the reactivities of 44 field serum samples from pigs on farms with a
porcine population suffering from postweaning multisystemic wasting syndrome. The recombinant nucleocap-
sid-based test was able to detect 15 more positive-testing pigs than the PCV2-based IFA. Therefore, the relative
sensitivity of the latter test was estimated at only 57.1% compared to that of the recombinant nucleocapsid-
based test. The recombinant fusion protein has been purified by affinity chromatography and is being used to
develop further sensitive serological tests.
Postweaning multisystemic wasting syndrome (PMWS) is an
emerging swine disease first described in Canada in 1991 (7,
13); subsequent outbreaks have frequently struck pig farms in
North and South America and in Europe and Asia (2, 3, 6, 15,
22, 28). The disease affects 5- to 12-week-old piglets and is
characterized in part by weight loss, dyspnea, jaundice, and
enlarged lymph nodes as well as by degeneration and necrosis
of hepatocytes, multifocal lymphohistiocytic pneumonia, lym-
phocytic depletion, and multinucleated giant cell formation
(13). Typically, morbidity rates can reach 5 to 50% in affected
herds, and mortality is close to 100% in pigs that develop the
full spectrum of symptoms associated with the disease (19).
The rapid and simultaneous emergence of the disease in many
different parts of the world as well as the uncertain mode of
transmission and high rates of mortality in pigs suffering from
PMWS has caused great concern throughout the swine indus-
try. The agent thought to be mainly responsible for PMWS has
been identified; a circovirus-like particle isolated from dis-
eased pigs was associated with the syndrome and named re-
combinant (rec) porcine circovirus type 2 (PCV2) (2, 11, 12).
The first porcine circovirus, now known as PCV1, was dis-
covered in 1974 as a nonpathogenic contaminant of the por-
cine kidney PK-15 cell line (27). It has since been characterized
as a small nonenveloped single-stranded DNA virus with a
1.76-kb ambisense genome (25). Antibodies against the virus
have been found in pigs worldwide, but no discernible patho-
genic properties have been associated with PCV1 infection in
swine (8, 10, 24). PCV2 isolated from pigs suffering from
PMWS displays a 76 to 83% amino acid identity with non-
pathogenic PCV1 and shares the same genomic organization,
consisting of two major open reading frames (ORFs) coding
for the replicase protein (Rep) and the nucleocapsid (NC)
protein, respectively (12, 18, 19). The 702-nucleotide ORF2
sequence coding for the PCV2 NC protein is located on the
complementary strand of the double-stranded replicative form
of the PCV2 genome and shares only 66% amino acid identity
with the sequence of the PCV1 ORF2, compared with an 85%
identity between the ORF1s of both viruses (12). These data
have led scientists to speculate that the PCV2 NC protein may
be at least in part responsible for the pathogenicity associated
with PCV2. Recently, several studies have suggested that the
28-kDa PCV2 NC protein is the major immunogenic protein of
the virus and the principal bearer of type-specific epitopes (14,
20).
PMWS is most commonly diagnosed on the basis of the
presence of histopathological lesions, its characteristic clinical
symptoms, and on the detection of PCV2 in the lesions (23).
Current methods most commonly used for the detection of
PCV2 in pigs include indirect immunofluorescence assays
(IFA) for PCV2-infected cells and PCR (21). Because the use
of PCR requires several time-consuming steps, IFA is gener-
ally preferred for rapid and inexpensive diagnosis of PMWS.
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However, IFA requires the prior infection of porcine cells with
live PCV2 virus, a procedure which can be very arduous be-
cause of its very slow replication cycle. The aim of this work
was to develop a rapid, easy-to-use, and inexpensive ORF2-
based serological diagnostic assay for PCV2 detection on the
basis of a rec PCV2 NC protein produced in a eucaryotic
expression system.
(This report was taken in part from a dissertation to be
submitted by S. Racine to the INRS-Institut Armand-Frappier,
Universite´ du Que´bec, in partial fulfillment of the require-
ments for the M.Sc. degree.)
MATERIALS AND METHODS
Virus, cells, and antisera. In a previous work, the IAF-2897 strain of PCV2
virus was isolated from lung tissue of young pigs with typical clinical signs of
PMWS in Quebec farms and its genome was entirely sequenced (GenBank
accession no. AF408635) (21). The virus was propagated in PCV1-free PK-15
porcine kidney (PKA) cells, which were graciously provided by A. Afshar (An-
imal Diseases Research Institute, Agriculture Canada, Nepean, Ontario, Can-
ada). Cells were infected at a very low level of confluence with purified virus and
grown in monolayers for 3 to 4 days in GIBCO minimal essential medium
(Invitrogen, Burlington, Ontario, Canada) supplemented with 5% fetal bovine
serum, 1 mM glutamine, 1% sodium pyruvate, and 100 M penicillin-strepto-
mycin. When cells reached confluence, supernatant was removed and cells were
washed three times with phosphate-buffered saline (PBS). The virus was har-
vested by freezing and thawing the infected cells three times in a small volume of
PBS. The resulting cell lysate was then clarified by centrifugation. Viral genomic
DNA was extracted from stocks of virus with TriPure DNA isolation reagent
(Roche Diagnostics, Laval, Quebec, Canada) according to the manufacturer’s
recommendations. Transfection experiments were carried out with the human
embryonic kidney 293 cell line (ATCC CRL-1573). Cells were grown in GIBCO
Dulbecco’s modified Eagle medium (Invitrogen) supplemented with 5% fetal
bovine serum, 1 mM glutamine, 1% sodium pyruvate, and 100 M penicillin-
streptomycin.
To produce a swine reference serum for use in serological tests of the IAF-
2897 strain of PCV2, four 5-week-old specific-pathogen-free pigs were injected
intranasally with 106 fluorescence units of semipurified PCV2 virus stock. Anti-
sera from inoculated pigs were tested weekly for the presence of PCV2-specific
antibodies until bleeding at 63 days postinfection (dpi). Negative-testing serum
samples were collected from two noninfected specific-pathogen-free piglets that
were maintained under the same conditions. A total of 44 field serum samples
collected from different groups of pigs from southern Quebec farms with porcine
populations suspected to be infected with PCV2 were provided by Biovet Inc.
(St-Hyacinthe, Quebec, Canada).
Cloning of PCV2 ORF2 in a eucaryotic expression vector. The PCV2 ORF2
sequence coding for the virus NC was amplified from the purified PCV2 DNA in
two successive PCRs using the primers described in Table 1. These primers were
designed to add a polyhistidine sequence to permit purification of the rec protein
by use of an affinity column and an enterokinase site for the subsequent removal
of the polyhistidine site. All primers overlap with each other or with the ORF2
sequence by 20 to 22 nucleotides. Both PCRs used Taq polymerase and consisted
of an initial enzyme activation step at 95°C for 5 min followed by 30 cycles of
denaturation at 94°C for 1 min, annealing at 48°C for 1 min, and extension at
72°C for 3 min and a final extension at 72°C for 10 min. The first PCR amplified
the ORF2 by use of the 6H-F2 no. 1 forward primer and the F2 reverse primer.
The resulting PCR product was then purified using a QIAGEN PCR purification
kit (QIAGEN Inc., Mississauga, Ontario, Canada). In the second PCR the
6H-F2 no. 2 forward primer was used with the same F2 reverse primer used
previously. A 780-nucleotide DNA sequence of the expected size was confirmed
by gel electrophoresis, and the final PCR product was then purified as previously
described.
The eucaryotic expression vector pCEP5 derived from the pCEP4 vector (9)
was obtained from the laboratory of A. Kamen (BRI, NRC, Montreal, Canada).
Both the vector and the final purified PCR product were digested with the
BamHI enzyme for 2 h at 37°C. The enzyme was subsequently inactivated by
incubation at 65°C for 20 min. The digested PCR product and plasmid were then
ligated using T4 DNA ligase at 14°C for 14 h. Escherichia coli DH5 competent
cells were transformed using the resulting pCEP-6H-ORF2 plasmid. Positive
clones were screened by PCR, restriction enzyme digestion, and DNA sequenc-
ing using the SeqpCEP primers detailed in Table 1.
Expression of the rec nucleocapsid protein. Transfection experiments were
carried out in either 96-well plaques or 60-cm2 petri dishes, and 293 or PKA cells
as well as polyethylenimine (PEI) gene transfer reagent (5) in its 25-kDa linear
form (Polysciences, Warrington, Pa.) were used for all transfection experiments.
Typically, 1 g of linear 25-kDa PEI was mixed with 1 g of pCEP5-6H-ORF2
DNA plasmid in a total volume of 100 l of GIBCO serum-free Dulbecco’s
modified Eagle medium. This mix was incubated at 37°C for 10 min, and then 20
l per well was added to the subconfluent 293 or PKA cell monolayers and
incubated in standard culture conditions for 48 h.
Expression of the PCV2 ORF2 in transfected cells was verified by IFA using
polyclonal PCV2 porcine sera from pigs experimentally infected with purified
PCV2, as well as sera from PCV-free pigs. Briefly, transfected cells were washed
with PBS and fixed with an acetone-methanol solution (1:1). Fixed cells were
then rehydrated with PBS for 10 min. PCV2-positive and -negative pig sera were
diluted at 1/100 in PBS with 0.15% Tween 20 and incubated with cells for 1 h at
37°C. Cells were washed three times with PBS and then incubated with rabbit
anti-pig immunoglobulin G–fluorescein isothiocyanate conjugate (Sigma-Al-
drich, Oakville, Ontario, Canada) diluted 1/100 in PBS during 45 min at 37°C.
Cells were finally observed and photographed with an epifluorescence micro-
scope (Leica; Leitz, Wetzlar, Germany). PCV2-infected PKA cells were also
used as controls as described above.
Purification and characterization of rec protein. 293 cells transfected with
pCEP5-6H-ORF2 expression vector in 100-mm-diameter petri dishes were lysed
with a cell lysis buffer (150 mM NaCl, 10 mM Tris [pH 7.8], 1% Triton X, 1%
sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS]) containing protease
inhibitors. The cell lysate was then solubilized by repeated passage through a
syringe and added to a HiTrap chelating affinity column (Amersham Pharmacia
Biotech, Baie d’Urfe´, Que´bec, Canada) per the manufacturer’s instructions.
Collected fractions were screened for the presence of the rec ORF2 protein by
SDS-polyacrylamide gel electrophoresis and Western blotting.
Collected fractions of purified 6H-ORF2 protein as well as nontransfected 293
cell lysate and purified virus preparation were analyzed by Western blotting.
Proteins were separated in SDS–12% polyacrylamide electrophoresis gels by use
of the standard method and transferred onto a nitrocellulose membrane (Bio-
Rad, Mississauga, Ontario, Canada), which was then incubated in blocking so-
lution (4% skim milk, 0.05% Tween 20 in PBS). Polyclonal anti-PCV2 serum, as
well as serum from PCV-free pigs, was diluted 1/500 in blocking solution and
incubated with the membranes for 1 h at room temperature. Membranes were
washed three times in PBS-Tween 20 and incubated for 1 h with a 1/1,000-diluted
solution of goat anti-porcine immunoglobulin G–peroxidase conjugate (Sigma)
in blocking solution. After three final washes, the blots were developed with
4-chloro-1-naphthol reagent (Bio-Rad).
TABLE 1. Oligonucleotide primers used for the construction and sequencing of the pCEP5-6H-ORF2 plasmid
Primer Sensea Sequenceb Length (bp)
6H-F2 no. 1 F 5-ACCATCACGGTGACGATGACGATAAGGATATGACGTATCCAAGGAGGCG-3 49
6H-F2 no. 2 F 5-CGCGGATCCGCGATGCATCACCATCACCATCACGGTGACGATGACGA-3 47
F2 R 5-CGCGGATCCGCGCGCGGATCCGCGTTAGGGTTTAAGTGGGGGGT-3 44
SeqpCEP-F F 5-GAGTGACAATGACATCCAC-3 19
SeqpCEP-R R 5-GTCCTTCCGAGTGAGAGAC-3 19
a F, forward; R, reverse.
b Nucleotide sequences corresponding to BamHI digestion sites are underlined, the polyhistidine sequences are boxed, the enterokinase digestion sites are in bold,
and nucleotides corresponding to the ORF2 sequence are italicized.
VOL. 11, 2004 USE OF PCV2 recNC FOR DIAGNOSIS OF PMWS BY IFA 737
Sensitivity and specificity of the IFA. All field serum samples were tested by
IFA on 96-well plaques of either 293 cells transfected with pCEP5-6H-ORF2 or
PKA cells infected with purified PCV2 as described previously. Serum dilutions
from 1/50 to 1/5,000 were used. Sera were considered positive for PCV2 at 1/50.
Specificity of both diagnostic tests for PCV2 was assayed by testing serum
samples from pigs infected with PCV1, porcine reproductive and respiratory
syndrome virus, porcine hemagglutinating encephalomyelitis coronavirus, and
Mycoplasma hyopneumoniae. The sensitivity values for both assays were deter-
mined using the following formulas, with the IFA performed on transfected 293
cells as a reference assay: (i) sensitivity  true positives/(true positives  false
negatives)  100 and (ii) specificity  true negatives/(true negatives  false
positives)  100.
RESULTS
Expression of the PCV2 NC protein in transfected cells. A
mix of purified plasmid DNA and linear 25-kDa PEI was used
to transfect subconfluent monolayers of 293 cells. Transfected
cells showed no sign of cellular damage that could be attrib-
uted to the presence of the PCV2 NC protein or the PEI
transfection reagent. The presence of the NC protein was
determined by IFA with various types of antibodies. Intense
and specific fluorescence was observed in the nuclei as well as
in the perinuclear regions of transfected cells. The pattern of
fluorescence was similar to that of PKA cells infected with
wild-type PCV2 (Fig. 1).
Transfected cells containing the recNC antigen reacted very
strongly to polyclonal anti-PCV2 antibodies but did not cross-
react with normal pig serum. The expression levels of the NC
protein in in vitro infections of PKA cells and in 293 cells
transfected with the pCEP-6H-ORF2 plasmid were compared
by IFA (Fig. 2). The proportion of cells expressing the PCV2
NC antigen was much higher in cells transfected with the
plasmid than in infected cells. Repeated experiments con-
firmed that, on average, the PCV2 recNC protein is expressed
at levels roughly 9 times higher in cells transfected with the
pCEP5-6H-ORF2 plasmid than in cells infected with the virus.
Characterization of the PCV2 recNC protein. Transfection
of subconfluent 293 cells in 60-mm-diameter petri dishes with
the pCEP-6H-ORF2 plasmid resulted in the production of a
significant quantity of PCV2 recNC which could then be re-
covered by cell lysis as described above. The resulting lysate
containing both cellular proteins and the PCV2 recNC antigen
FIG. 1. Localization of the ORF2 protein in transfected cells. Fluorescence was localized in the peri- and intranuclear regions of 293 cells
transfected with the pCEP5-6H-ORF2 plasmid (a). This specific fluorescence is similar to that observed in PCV2-infected PKA cells (b). To
facilitate observation, the 293 cells were transfected with a suboptimal quantity of pCEP5-6H-ORF2 DNA.
FIG. 2. IFA comparison of PCV2 NC expression levels in PCV2-
infected PKA cells and 293 cells transfected with pCEP5-6H-ORF2.
(A) PKA cells infected with PCV2. (B) Mock-infected PKA cells.
(C) 293 cells transfected with pCEP5-6H-ORF2. (D) Nontransfected
293 control cells. Cells were incubated with either polyclonal anti-
PCV2 pig serum (positive serum) or PCV-negative pig serum (negative
serum).
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was purified by passage through an Ni affinity column. Both the
total protein from the cell lysate and the purified recNC re-
acted specifically in immunoblotting with polyclonal anti-
PCV2 serum at a 1/500 dilution (Fig. 3, lanes 2 and 3). The
recNC protein had an observed molecular mass of 32 kDa.
Concentrated and purified PCV2 virus was used as a control
antigen (Fig. 3, lane 4) and produced a specific reaction at a
molecular mass of 29 kDa. Neither the recNC nor the purified
PCV2 virus reacted with PCV2-negative swine serum.
Accuracy of the rec ORF2-based diagnostic IFA. The accu-
racy of the test was verified by comparing both the classic IFA
diagnostic test using PCV2-infected PKA cells (classic IFA)
and the recNC-based test (recNC IFA). All 44 porcine serum
samples collected from PMWS-affected swine farms were
tested using both IFA tests, and the observed results are sum-
marized in Table 2. A total of 23 serum samples were positive
for PCV2-specific antibodies by the PCV2-based test, while 35
serum samples were positive by the recNC-based test. The
sensitivity of the classic IFA versus that of the recNC-based
test is 57.1% when the latter is used as the reference assay. A
total of 15 serum samples that were negative in the classic IFA
were considered positive in the recNC IFA.
Among the 35 serum samples that tested positive for PCV2
antibodies in the recNC-based test, 10 showed antibody titers
greater than 5,000 whereas only 3 showed antibody levels
greater than 2,500 in the classic IFA. Serum samples from six
pigs that tested negative in the classic IFA produced antibody
titers over 2,500 with the new IFA test. Overall, 25 serum
samples produced a significantly higher antibody titer with the
recNC IFA than with the classic IFA. In addition, seven pos-
itive-testing serum samples gave roughly equal titers and nine
were negative with both assays. Only three samples had anti-
body titers that were lower with the recNC IFA than with the
classic IFA.
Positive-control sera from pigs infected with PCV1, porcine
reproductive and respiratory syndrome virus, hemagglutinating
encephalomyelitis coronavirus, or M. hyopneumoniae were also
tested with both IFA (data not shown). Some nonspecific back-
ground fluorescence was observed among PCV2-infected PKA
cells, but no reactivity whatsoever was observed in cells trans-
fected with the pCEP5-6H-ORF2 plasmid. As a result, both
IFA diagnostic tests had a specificity of 100%.
DISCUSSION
The dramatic increase in reported outbreaks of PMWS in
pig farms in recent years has been an additional burden for pig
producers already under pressure from the threat of other pig
pathogens, increased public scrutiny, and intense competition
in the marketplace. Early detection of PCV2 in pigs is essential
to help contain the spread of the virus and of PMWS. The goal
of the present study was to conceive a very specific and ex-
tremely sensitive but low-cost and easy-to-use test to help in
the diagnosis of cases of early PCV2 infection in pigs. The IFA
is probably the most commonly used method for the detection
of PCV2 antibodies in pig serum, as it is faster and less expen-
sive than PCR tests and does not require specialized equip-
ment. However, the use of live PCV2 to infect cells used in IFA
has always been problematic at best. Because the virus does
not produce a visible cytopathic effect in infected cells and
replicates only in cells currently undergoing mitosis, PCV2
infections yield very small amounts of virus (1). The use of
D-glucosamine to stimulate the entry of cells in the S phase of
mitosis to accelerate the replication of PCV2 has been sug-
gested previously (26). However, it was also reported to be
problematic because of its high level of cellular toxicity and
therefore should generally be avoided when possible (1). There
is also evidence of antigenic cross-reactivity between the Rep
proteins of PCV1 and PCV2, which could generate false diag-
nostic results. Recent studies have demonstrated that the
ORF1-encoded proteins in the two viruses were antigenically
related whereas the ORF2 proteins were recognized differen-
tially by polyclonal anti-PCV2 antibodies (4, 16, 17). No cross-
reactivity was demonstrated between the NC proteins of the
two viruses (29).
To circumvent the previous problems, the ORF2 gene from
the PCV2 virus was cloned into a pCEP5 eucaryotic expression
vector bearing a CMV2 promoter. The resulting pCEP5-6H-
ORF2 plasmid was used to transfect cells that could then
express the viral NC protein. Initial attempts to transfect PKA
cells with the plasmid and either PEI or fuGENE6 transfection
reagents (Roche Diagnostics) were a failure. No plasmid DNA
was detected in the cytoplasm or the nuclei of transfected cells.
Alternatively, 293 cells had previously been used successfully in
conjunction with the pCEP5 vector and PEI (9). Subsequent
transfection experiments with pCEP5-6H-ORF2 consistently
produced clear and distinct fluorescence in the nucleus and the
perinuclear area of the 293 cells (Fig. 1). This fluorescence
pattern was identical to that observed in naturally infected
PKA cells, but background fluorescence was markedly lower in
transfected cells.
The proportion of transfected cells expressing the PCV2
FIG. 3. Expression and purification of rec 6H-ORF2 protein and
reactivity with polyclonal anti-PCV2 pig serum and PCV-negative se-
rum in Western blotting. Lane 1, nontransfected 293 cell lysate; lane 2,
total protein in cell lysate from 293 cells transfected with pCEP5-6H-
ORF2; lane 3, 6H-ORF2 protein partially purified in a HiTrap che-
lating affinity column; lane 4, total protein in cell lysate from concen-
trated purified PCV2.
TABLE 2. Comparison between IFA for the serologic detection of
specific PCV2 antibodies in pigs
Classic IFA result
No. (%) of serum samples with indicated result
by recNC IFA
Positive Negative Total
Positive 20 (45.5) 3 (6.8) 23 (52.3)
Negative 15 (34.1) 6 (13.6) 21 (47.7)
Total 35 (79.6) 9 (20.4) 44 (100.0)
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recNC was roughly proportional to the quantity of plasmid
DNA used in the transfection mix. Fluorescent cells may be
observed with as little as 40 ng of plasmid DNA per well in a
96-well plate, the optimal amount of plasmid being about 200
to 300 ng per well. By use of these conditions, transfection of
293 cells with the plasmid generated on average 9 times more
fluorescent cells expressing the PCV2 NC than transfection of
PKA cells infected with the virus (Fig. 2). In addition, trans-
fections of 293 cells in 60-mm-diameter petri dishes under the
same transfection conditions yielded significantly larger quan-
tities of NC product than transfection of PKA cells infected
with PCV2 under the same culture conditions. The addition of
a polyhistidine tag to the recNC protein allowed quick and easy
purification and concentration of the protein by affinity chro-
matography with a metal chelate affinity column. Purified and
nonpurified recNC from cell lysate analyzed by Western blot-
ting reacted strongly with PCV2-specific antibodies (Fig. 3). As
expected, the addition of the polyhistidine tag and the en-
terokinase restriction site to the NC amino acid sequence in-
creased the molecular mass of the protein to roughly 32 kDa
compared to about 29 kDa for the native protein. These results
suggest that the recNC protein expressed in transfected cells is
immunogenically identical to the native protein.
To determine whether recNC IFA using cells transfected
with the pCEP-6H-ORF2 plasmid can be used as an accurate
diagnostic tool for the detection of PCV2-specific antibodies in
pigs, 44 swine serum samples from several porcine farms in
southern Quebec that have had recurrent problems with
PMWS outbreaks in the past years have been analyzed. Each
serum sample was tested by classic IFA using a diagnostic
protocol from local laboratories and by recNC IFA as de-
scribed in the present study (Table 2). The results strongly
indicate that the recNC IFA was able to detect much smaller
amounts of antibodies in serum, as evidenced by comparing
several serial serum dilutions in each test, and it is therefore a
much more sensitive assay. The sensitivity of the classic IFA
was only 57.1% compared to that of the recNC IFA. Of the 44
serum samples tested, only three samples that were considered
to be positive using the classic IFA were shown to be negative
with the recNC IFA. This could be explained by the high
amount of background fluorescence often observed in classic
IFA, particularly at low serum dilutions. However, fluores-
cence in transfected cells is strongly localized in the cell nu-
cleus even under conditions of incubation with low serum
dilutions. It is noteworthy that both IFA tests were also used
with sera collected at different times postinfection from piglets
experimentally infected with PCV2. The recNC IFA was able
to detect the presence of PCV2-specific antibodies in serum as
early as 7 dpi compared to 14 dpi for the classic IFA.
The results presented in this report indicate that an IFA
diagnostic test using PCV2 recNC antigen expressed from
transfected cells can quickly and accurately detect even small
amounts of PCV2 antibodies in pig sera. The sensitivity of the
assay is much improved compared to that of the classic IFA
method using virus-infected cells. This system is particularly
advantageous, because very large amounts of protein can be
rapidly and inexpensively produced compared to the results
seen with PCV2 infections, which can be relatively difficult to
perform and produce only small quantities of virus. In addi-
tion, the recNC protein can be immediately purified and con-
centrated by affinity chromatography and can subsequently be
used as an antigen for enzyme-linked immunosorbent assays
and Western blot analyses and for further characterization
studies. Additional work is necessary to determine whether the
protein might be used as a subunit vaccine in pigs to prevent
infection by PCV2.
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